Characteristics and Outcomes of IBD Patients With COVID-19 on Tofacitinib Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Inflammatory Bowel Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Characteristics and Outcomes of IBD Patients With COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
Inflamm. Bowel Dis. 2020 Dec 16;[EPub Ahead of Print], M Agrawal, EJ Brenner, X Zhang, I Modesto, J Woolcott, RC Ungaro, JF Colombel, MD KappelmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.